Over the past 12 months, 0 insiders at Coherus BioSciences, Inc. filed 0 open-market SEC Form 4 transactions on CHRS: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 23, 25 | Mats WahlstromDirector | SELL | 100.0K | $0.74 | $74K |
| Nov 22, 23 | Dennis M LanfearPresident & CEO | SELL | 223.1K | $2.02 | $451K |
| Oct 15, 21 | McDavid StilwellChief Financial Officer | SELL | 3.5K | $16.80 | $59K |
| Sep 29, 21 | James HealyDirector | SELL | 286.1K | $16.12 | $4.6M |
| Sep 28, 21 | James HealyDirector | SELL | 48.3K | $17.17 | $830K |
| Sep 27, 21 | James HealyDirector | SELL | 100.2K | $18.06 | $1.8M |
Over the past 12 months, insiders at Coherus BioSciences, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on CHRS, which makes them mixed over the period. The most recent Form 4 was filed on .
0 different insiders at Coherus BioSciences, Inc. filed open-market SEC Form 4 transactions on CHRS over the last 12 months.
InsiderTape plots every CHRS insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Coherus BioSciences, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →